Apidemia IVS: Financial statements 2020
CVR: 37503312
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Apidemia IVS (CVR 37503312) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 161,017 and a net result of DKK -201,443 compared with DKK 59,896 the year before. That is a decrease of 50% compared with the year before. Equity in the 2020 report amounted to DKK -1,142,472. The company had 2 employees in the financial year.
- Gross Profit
- DKK 161,017
- Profit/Loss
- DKK -201,443
- Equity
- DKK -1,142,472
- Total Assets
- DKK 214,355
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 161 t. | -201 t. | -1.1 mio. | 2 |
| 2019 | - | 322 t. | 60 t. | -941 t. | 1 |
| 2018 | - | 211 t. | -355 t. | -1 mio. | 2 |
| 2017 | - | 243 t. | -384 t. | -646 t. | 2 |
| 2016 | - | -105 t. | -262 t. | -262 t. | 1 |
Official annual report
How creditworthy is Apidemia IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Apidemia IVS has published its annual report for 2019. Gross profit came to DKK 322,296, and the net result was DKK 59,896.
About Apidemia IVS
Apidemia IVS was a Danish company of the type Iværksætterselskab based in Aarhus C, founded in 2016. The company has been dissolved on 10 November 2022. The company was registered under the industry Konsulentbistand vedrørende informationsteknologi. The company was previously named dotboost IVS. The company has 2 employees (2021). In 2020, the company reported a gross profit of DKK 161,017 and a net result of DKK -201,443 compared with DKK 59,896 the year before. Equity in the 2020 report amounted to DKK -1,142,472.